Pfizer 1 XNB (Inlyta 1 mg)
Generic Name: axitinib
Pill imprint Pfizer 1 XNB has been identified as Inlyta 1 mg.
Inlyta is used in the treatment of renal cell carcinoma and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Inlyta 1 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- axitinib
- Imprint:
- Pfizer 1 XNB
- Strength:
- 1 mg
- Color:
- Red
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Multikinase inhibitors
VEGF/VEGFR inhibitors - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Pfizer Inc.
- National Drug Code (NDC):
- 00069-0145
- Inactive Ingredients:
- microcrystalline cellulose
lactose monohydrate
croscarmellose sodium
magnesium stearate
titanium dioxide
triacetin
ferric oxide red
hypromellose 2910 (15000 mPa.s)
More about Inlyta (axitinib)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
